T2Biothreat Panel Receives FDA 510(k) Clearance
T2 Biosystems, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat Panel.
Read MorePosted by Chris Wolski | Sep 19, 2023 | Sepsis |
T2 Biosystems, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat Panel.
Read MorePosted by Andy Lundin | Sep 18, 2023 | Diagnostic Technologies |
The Icahn School of Medicine at Mount Sinai agreed to an exclusive license option with GNOMX Corp. for the disease diagnostic tech.
Read MorePosted by Andy Lundin | Sep 18, 2023 | Tubes |
Azenta Life Sciences’ new 0.2ml PCR microcentrifuge tube features a novel dual-cap design with both hinged lid and screw cap.
Read MorePosted by Chris Wolski | Sep 6, 2023 | Lab Management |
Understanding the prevalence of pharmacies and lab capacity to accelerate test and treat opportunities, improves the health care enterprise.
Read MorePosted by Chris Wolski | Sep 1, 2023 | Cervical (HPV) |
Self-collection could be an effective way to increase access to screening for cervical cancer, diagnosing the disease earlier.
Read More